Additional Efficiencies In "Abbreviated" 510(k) Process Sought By FDA
This article was originally published in The Gray Sheet
Executive SummaryFDA may begin identifying devices that would make good candidates for its "abbreviated" 510(k) process as a way to boost industry interest in the recently initiated program.
You may also be interested in...
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.
Israel-based Binah.ai hopes to earn regulatory approval for a video-based monitoring app that can detect vital signs in minutes. See what Binah.ai's co-founder and CEO, David Maman, said about the technology here.